Key Takeaways GLP-1 receptor agonists, including Tirzepatide, Semaglutide, and Liraglutide, are effective in promoting weight loss and improving glycemic control, with varying degrees of effectiveness and administration schedules
Contains: 4 x 0.5 mL Single-Dose Prefilled Syringes Push to open PACKAGE/LABEL PRINCIPAL DISPLAY PANEL 1.7 mg Manual Prefilled Syringe NDC 0169-1617-14 List 161714 wegovy 1.7 mg (semaglutide) injection 1.7 mg/0.5 mL Use Wegovy 1 time a week For subcutaneous use only Each prefilled syringe delivers 1.7 mg semaglutide Rx only Dispense the enclosed Medication Guide to each patient
It can lead to death, which is why patients are typically asked to fast before surgery
For individuals with BMI above 30 or BMI above 27 with comorbidities, FDA-approved GLP-1 receptor agonists (semaglutide, tirzepatide) have far stronger evidence and produce dramatically greater weight loss
Unique mouth-melt formulation for rapid absorption
In: DiPiro JT, Yee GC, Haines ST, et al, eds